Literature DB >> 19589779

Long range communication between exosites 1 and 2 modulates thrombin function.

Nicolas S Petrera1, Alan R Stafford, Beverly A Leslie, Colin A Kretz, James C Fredenburgh, Jeffrey I Weitz.   

Abstract

Although exosites 1 and 2 regulate thrombin activity by binding substrates and cofactors and by allosterically modulating the active site, it is unclear whether there is direct allosteric linkage between the two exosites. To begin to address this, we first titrated a thrombin variant fluorescently labeled at exosite 1 with exosite 2 ligands, HD22 (a DNA aptamer), gamma'-peptide (an analog of the COOH terminus of the gamma'-chain of fibrinogen) or heparin. Concentration-dependent and saturable changes in fluorescence were elicited, supporting inter-exosite linkage. To explore the functional consequences of this phenomenon, we evaluated the capacity of exosite 2 ligands to inhibit thrombin binding to gamma(A)/gamma(A)-fibrin, an interaction mediated solely by exosite 1. When gamma(A)/gamma(A)-fibrinogen was clotted with thrombin in the presence of HD22, gamma'-peptide, or prothrombin fragment 2 there was a dose-dependent and saturable decrease in thrombin binding to the resultant fibrin clots. Furthermore, HD22 reduced the affinity of thrombin for gamma(A)/gamma(A)-fibrin 6-fold and accelerated the dissociation of thrombin from preformed gamma(A)/gamma(A)-fibrin clots. Similar responses were obtained when surface plasmon resonance was used to monitor the interaction of thrombin with gamma(A)/gamma(A)-fibrinogen or fibrin. There is bidirectional communication between the exosites, because exosite 1 ligands, HD1 (a DNA aptamer) or hirudin-(54-65) (an analog of the COOH terminus of hirudin), inhibited the exosite 2-mediated interaction of thrombin with immobilized gamma'-peptide. These findings provide evidence for long range allosteric linkage between exosites 1 and 2 on thrombin, revealing further complexity to the mechanisms of thrombin regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589779      PMCID: PMC2757964          DOI: 10.1074/jbc.M109.000042

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.

Authors:  Ingrid M Verhamme; Steven T Olson; Douglas M Tollefsen; Paul E Bock
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

2.  Fibrinogen gamma' chain binds thrombin exosite II.

Authors:  R S Lovely; M Moaddel; D H Farrell
Journal:  J Thromb Haemost       Date:  2003-01       Impact factor: 5.824

3.  Molecular dissection of Na+ binding to thrombin.

Authors:  Agustin O Pineda; Christopher J Carrell; Leslie A Bush; Swati Prasad; Sonia Caccia; Zhi-Wei Chen; F Scott Mathews; Enrico Di Cera
Journal:  J Biol Chem       Date:  2004-05-19       Impact factor: 5.157

4.  Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin.

Authors:  Caroline H Pospisil; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

5.  The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III.

Authors:  F J Walker; C T Esmon
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

6.  Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin.

Authors:  S T Olson; J D Shore
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

7.  Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.

Authors:  Trevor P Baglin; Robin W Carrell; Frank C Church; Charles T Esmon; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

8.  Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.

Authors:  J Müller; D Freitag; G Mayer; B Pötzsch
Journal:  J Thromb Haemost       Date:  2008-09-27       Impact factor: 5.824

9.  The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin.

Authors:  W G Owen; C T Esmon; C M Jackson
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

10.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.

Authors:  C T Esmon; N L Esmon; K W Harris
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

View more
  21 in total

1.  Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

2.  Effect of zymogen domains and active site occupation on activation of prothrombin by von Willebrand factor-binding protein.

Authors:  Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

3.  A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.

Authors:  K M Bompiani; D M Monroe; F C Church; B A Sullenger
Journal:  J Thromb Haemost       Date:  2012-05       Impact factor: 5.824

4.  Protease-resistant peptide ligands from a knottin scaffold library.

Authors:  Jennifer A Getz; Jeffrey J Rice; Patrick S Daugherty
Journal:  ACS Chem Biol       Date:  2011-06-16       Impact factor: 5.100

5.  Through-bond effects in the ternary complexes of thrombin sandwiched by two DNA aptamers.

Authors:  Andrea Pica; Irene Russo Krauss; Valeria Parente; Hisae Tateishi-Karimata; Satoru Nagatoishi; Kouhei Tsumoto; Naoki Sugimoto; Filomena Sica
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

6.  Novel heparin mimetics reveal cooperativity between exosite 2 and sodium-binding site of thrombin.

Authors:  May H Abdel Aziz; Umesh R Desai
Journal:  Thromb Res       Date:  2018-03-17       Impact factor: 3.944

7.  Molecular dynamics simulations of aptamer-binding reveal generalized allostery in thrombin.

Authors:  Jiajie Xiao; Freddie R Salsbury
Journal:  J Biomol Struct Dyn       Date:  2016-11-29

8.  Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

9.  Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I.

Authors:  Ramya Billur; David Ban; T Michael Sabo; Muriel C Maurer
Journal:  Biochemistry       Date:  2017-11-21       Impact factor: 3.162

10.  Ligand binding to anion-binding exosites regulates conformational properties of thrombin.

Authors:  Marina V Malovichko; T Michael Sabo; Muriel C Maurer
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.